BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 25539748)

  • 1. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
    He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
    Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
    AlGhamdi KM; AlShammari SA
    Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life.
    Milutinović JD; Krstić N; Janković SM
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Spanish version of Skindex-29.
    Jones-Caballero M; Peñas PF; García-Díez A; Badía X; Chren MM
    Int J Dermatol; 2000 Dec; 39(12):907-12. PubMed ID: 11168659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.
    Essa N; Awad S; Nashaat M
    Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
    Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM
    J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turkish version of Skindex-29.
    Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
    Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
    Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
    PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco.
    El Fakir S; Baybay H; Bendahhou K; Obtel M; Benchat L; Mernissi FZ; Nejjari C
    J Dermatolog Treat; 2014 Apr; 25(2):106-9. PubMed ID: 22455447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross validation of the Turkish version of dermatology life quality index.
    Oztürkcan S; Ermertcan AT; Eser E; Sahin MT
    Int J Dermatol; 2006 Nov; 45(11):1300-7. PubMed ID: 17076710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Skindex-29 Questionnaire: Portuguese Version (Portugal).
    Carvalho D; Aguiar P; Palma-Carlos A
    Acta Med Port; 2018 Sep; 31(9):463-469. PubMed ID: 30332369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
    He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
    Chren MM; Lasek RJ; Sahay AP; Sands LP
    J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese version of the Family Dermatology Life Quality Index: Translation and validation.
    Higaki Y; Tanaka M; Futei Y; Kamo T; Basra MKA; Finlay AY
    J Dermatol; 2017 Aug; 44(8):914-919. PubMed ID: 28342225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients.
    Abeni D; Picardi A; Pasquini P; Melchi CF; Chren MM
    Dermatology; 2002; 204(1):43-9. PubMed ID: 11834849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric characteristics of DLQI-BRA and Skindex-16 to measure the impact of dermatological diseases on quality of life in Brazilian patients.
    Meneguin S; de Souza Matos TD; Pollo CF; Garuzi M; Miot HA; de Oliveira C
    PLoS One; 2021; 16(8):e0254882. PubMed ID: 34388159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation and psychometric validation of a Danish version of the medication-related quality of life scale.
    Lech LVJ; Jónsdóttir ED; Niclasen J; Treldal C; Graabæk T; Almarsdóttir AB
    Int J Clin Pharm; 2020 Apr; 42(2):667-676. PubMed ID: 32026349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the Chinese version of dry eye related quality of life scale.
    Zheng B; Liu XJ; Sun YF; Su JZ; Zhao Y; Xie Z; Yu GY
    Health Qual Life Outcomes; 2017 Jul; 15(1):145. PubMed ID: 28716084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine.
    Chang HY; Jensen MP; Yang CC; Lai YH
    Health Qual Life Outcomes; 2019 Jun; 17(1):108. PubMed ID: 31234894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability and validity of Chinese version of SF36 v2 in aging patients with chronic heart failure.
    Dong A; Chen S; Zhu L; Shi L; Cai Y; Zeng J; Guo W
    Aging Clin Exp Res; 2017 Aug; 29(4):685-693. PubMed ID: 27518815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.